Advair, the first inhaler that combines BOTH a long-acting bronchodilator (salmeterol) and corticosteroid (fluticasone)
October 1999
Glaxo will soon market Advair, the first inhaler that combines BOTH a long-acting bronchodilator (salmeterol) and corticosteroid (fluticasone).
Advair is a Diskus inhaler that comes in 3 strengths...100, 250, or 500 mcg fluticasone per inhalation. All strengths also contain 50 mcg of salmeterol per puff.
Patients will use Advair twice daily to PREVENT asthma symptoms. They will still need a short-acting bronchodilator to TREAT an acute attack.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive